Sign Up

Ozempic maker Novo Nordisk trims down its forecasts AGAIN in battle of the fat jabs

Daily Mail 1 min read 8 hours ago

Novo's new boss Mike Doustdar (pictured) is battling to turn around its fortunes amid competition from Eli Lilly, which makes Mounjaro.
Read original Daily Mail

More from Daily Mail

JONATHAN DAVIES: The Welsh rugby crisis was always coming - they papered over the cracks with the golden generation and the clubs aren't blameless either
Ademola Lookman in fierce altercation with his OWN manager: Ex-Premier League star has to be separated from Atalanta boss as they almost come to blows after player's furious reaction to being substituted
Is this 2025's 'Wheelie Bin girl'? Excruciating moment Melbourne Cup racegoer tries to ride a horse  statue- before getting told off by the police
Grieving Serbian football team hold emotional memorial service for 'inspirational' manager who collapsed and died mid-match

Related in Business

Wetherspoons boss warns rising costs could add 15p to the price of a pint
Back to the future at M&S: The High Street favourite is showing investors some mettle, says ALEX BRUMMER
Weak demand takes shine off Pandora as the jewellery brand pins its hopes on a Christmas recovery
Footsie hits new record high as investors brush off fears AI bubble will burst - at least for now